Biochemical, structural and molecular dissection of androgen receptor transcriptional activity
雄激素受体转录活性的生化、结构和分子剖析
基本信息
- 批准号:10655002
- 负责人:
- 金额:$ 24.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AffinityAndrogen AntagonistsAndrogen ReceptorAndrogen-Insensitivity SyndromeAndrogensArchitectureAtomic Force MicroscopyBindingBiochemicalBiologicalBiological AssayBiologyCancer BiologyCell LineCellsCellular MorphologyChIP-seqChromatinCommunicationComplexConsensusCryoelectron MicroscopyDNADNA BindingDNA Binding DomainDevelopmentDimerizationDiseaseDissectionDrug TargetingElectron MicroscopyElectronsEtiologyGenerationsGenetic TranscriptionGlobal ChangeGlucocorticoid ReceptorGoalsGrowthHealthIn VitroJointsKennedy SyndromeKnowledgeLaboratoriesLeadershipLentivirusLigand Binding DomainMaintenanceMale Pattern BaldnessMalignant neoplasm of prostateMediatingMemorial Sloan-Kettering Cancer CenterMetastatic Prostate CancerMetastatic toMethodsMineralocorticoid ReceptorModelingMolecularMolecular ConformationMutateMutationN-terminalNational Institute of General Medical SciencesNegative StainingNuclear Hormone ReceptorsNucleoproteinsOutputPhenotypePhenotypic SexProcessProgesterone ReceptorsProstateProteinsReceptor ActivationReceptor InhibitionReceptor SignalingRecombinant ProteinsRecombinantsRegulationReporterReportingResearchResearch PersonnelResolutionRunningSex DifferentiationSexual DevelopmentSiteStanoloneStructural ModelsStructureSurfaceSystemTestingTestosteroneTrainingTransactivationTranscriptTranscriptional RegulationUniversitiesUrsidae FamilyValidationVariantWorkX-Ray Crystallographybasecareercastration resistant prostate cancercell growthcofactorcomputerized data processingdata acquisitiondesignenzalutamideexperienceflexibilityfunctional outcomesgenetic corepressorhuman diseaseimprovedin vivoinhibitorinnovationinsightmalemutantnovelparticlepost-doctoral trainingprostate cancer cellprotein protein interactionreceptor bindingskillsstructural biologythree-dimensional modelingtranscription factortranscriptometranscriptome sequencing
项目摘要
PROJECT SUMMARY AND ABSTRACT
The androgen receptor (AR) is the master transcription factor responsible for development and maintenance of
the male sex phenotype. Aberrant AR activity is associated with multiple disorders, including but not limited to
metastatic prostate cancer, androgenetic alopecia, and Kennedy's disease. Cell-based studies have reported
AR is regulated through numerous processes, including 1) androgen stimulation; 2) anti-androgen inhibition; 3)
intramolecular contacts among its domains; 4) association with various protein coactivators and corepressors.
Despite its importance in disease etiology, the mechanistic details underlying AR regulation are largely
unknown due to historical difficulty isolating pure, active multidomain AR variants.
This research will employ biochemical and complementary structural methods – including electron and atomic
force microscopy, and x-ray crystallography – to illuminate the molecular determinants of AR activation through
identification of surfaces important for intramolecular and cofactor-mediated stimulation (Aim 1), and for AR
inhibition by anti-androgen binding and self-regulatory modes of autoinhibition (Aim 3). The molecular details
revealed by the biochemical and structural studies will be validated in biologically relevant AR-dependent cell
lines to determine the functional outcomes of these interactions on cell morphology, growth, AR signaling and
the AR cistrome (Aim 2). The findings from these studies will provide novel insight for modes of dimerization,
intramolecular regulation, and DNA binding for AR as well as other type I nuclear hormone receptors, including
the progesterone, glucocorticoid, and mineralocorticoid receptors, and can facilitate potential design of novel
AR-targeting drugs. This research is in line with the goals of the NIGMS of generating fundamental knowledge
that will bear implication for human disease and health.
The comprehensive training plan described will enable the investigator to achieve her career goals of running
an independent academic laboratory dedicated to studying fundamental modes of AR transcriptional regulation
in the context of its active, hyperactivated, and inhibited states, and will provide biochemical, structural, and
functional insight to the consequences of its aberrant activity in disease. As a joint mentee in top prostate
cancer and structural biology laboratories at Memorial Sloan Kettering Cancer Center and the Rockefeller
University, she will receive diverse training in prostate biology and electron microscopy that will expand the
investigator's biological understanding and technical repertoire that will enable significant innovation in her
future research. The leadership, networking, and communication skills she will acquire through the MOSAIC
UE5 will facilitate her transition to independence, and equip her to enhance diversity in the scientific workforce.
项目总结和摘要
雄激素受体(AR)是负责发育和维持的主要转录因子,
男性性别表型。异常AR活性与多种疾病相关,包括但不限于
转移性前列腺癌、雄激素性脱发和肯尼迪病。基于细胞的研究报告说,
AR通过许多过程调节,包括1)雄激素刺激; 2)抗雄激素抑制; 3)
其结构域之间的分子内接触; 4)与各种蛋白质共激活子和共阻遏子的缔合。
尽管其在疾病病因学中的重要性,但AR调节的机制细节在很大程度上是未知的。
由于分离纯的、活性多结构域AR变体的历史困难而未知。
这项研究将采用生物化学和互补结构的方法-包括电子和原子
力显微镜和X射线晶体学-通过以下方式阐明AR激活的分子决定因素:
识别对分子内和辅因子介导的刺激(Aim 1)以及AR重要的表面
通过抗雄激素结合和自我抑制的自我调节模式进行抑制(目的3)。的分子层析的细节
将在生物学相关的AR依赖性细胞中验证生物化学和结构研究所揭示的
细胞系,以确定这些相互作用对细胞形态、生长、AR信号传导和
AR顺反子(Aim 2)。这些研究的发现将为二聚化模式提供新的见解,
分子内调节和AR以及其他I型核激素受体的DNA结合,包括
孕酮、糖皮质激素和盐皮质激素受体,并且可以促进潜在的设计新的
AR靶向药物这项研究符合NIGMS产生基础知识的目标
这将对人类疾病和健康产生影响。
所描述的全面培训计划将使调查员能够实现她的职业目标,
一个独立的学术实验室,致力于研究AR转录调控的基本模式
在其活性,超活化和抑制状态的背景下,并将提供生物化学,结构,
功能洞察其异常活动的疾病后果。作为一个联合学员在顶部前列腺
纪念斯隆-凯特琳癌症中心和洛克菲勒中心的癌症和结构生物学实验室
大学期间,她将接受前列腺生物学和电子显微镜方面的各种培训,
研究人员的生物学理解和技术技能,将使她的重大创新,
未来的研究。她将通过MOSAIC获得的领导力、网络和沟通技能
UE 5将促进她向独立的过渡,并使她能够增强科学劳动力的多样性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elizabeth Victorina Wasmuth其他文献
Elizabeth Victorina Wasmuth的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elizabeth Victorina Wasmuth', 18)}}的其他基金
Biochemical, structural and molecular dissection of androgen receptor transcriptional activity
雄激素受体转录活性的生化、结构和分子剖析
- 批准号:
10321278 - 财政年份:2021
- 资助金额:
$ 24.9万 - 项目类别:
Structural and Biochemical Characterization of the S. cerevisiae RNA Exosome
酿酒酵母 RNA 外泌体的结构和生化特征
- 批准号:
8126951 - 财政年份:2011
- 资助金额:
$ 24.9万 - 项目类别:
Structural and Biochemical Characterization of the S. cerevisiae RNA Exosome
酿酒酵母 RNA 外泌体的结构和生化特征
- 批准号:
8391785 - 财政年份:2011
- 资助金额:
$ 24.9万 - 项目类别:
Structural and Biochemical Characterization of the S. cerevisiae RNA Exosome
酿酒酵母 RNA 外泌体的结构和生化特征
- 批准号:
8520346 - 财政年份:2011
- 资助金额:
$ 24.9万 - 项目类别:
Structural and Biochemical Characterization of the S. cerevisiae RNA Exosome
酿酒酵母 RNA 外泌体的结构和生化特征
- 批准号:
8705540 - 财政年份:2011
- 资助金额:
$ 24.9万 - 项目类别: